Genedrive PLC - Manchester-based molecular diagnostics firm - Wins Public Health England deal under Lot 1 of National Microbiology Framework. Lot 1 relates to supply of diagnostic goods and services. "The award of a framework contract is not exclusive to the company, nor a guarantee of orders, however it does allow participating authorities to issue call-off orders for products in the future," Genedrive says.
Current stock price: 73.36 pence, up 9.5% on Monday
Year-to-date change: up 51%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Genedrive (GDR)